NADELEINBRINGUNG DURCH ÜBERDRUCK

Patent europeic · EP3592402 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3592402
Numer da la dumonda
EP18708303
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
20-02-2018
Publitgà
15-01-2020
Concedì
01-04-2026
La protecziun finescha il pli tard
19-02-2038
Proxima taxa annuala scadenta
28-02-2027
Classas IPC
A61M 5/14 (2006.01)
A61M 5/158 (2006.01)
A61M 5/142 (2006.01)
Prioritad
US 201762468190 P 07.03.2017
Dumonda PCT
PCT/US2018/018687 20.02.2018
Publicaziun PCT
WO2018/164829 13.09.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 01.04.2026

Partidas

Possessur

Amgen Inc.

One Amgen Center Drive, Thousand Oaks, California 91320-1799, US

Inventur

MCCULLOUGH, Adam, B.

Westlake Village, CA 91362, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.